OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-κB binding sites

被引:20
作者
Tone, Yukiko
Kojima, Yoshitsugu
Furuuchi, Keiji
Brady, Maya
Yashiro-Ohtani, Yumi
Tykocinski, Mark L.
Tone, Masahide
机构
[1] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[2] Univ Penn, Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.179.3.1760
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OX40 is a member of the TNFR superfamily (CD134; TNFRSF4) that is expressed on activated T cells and regulates T cell-mediated immune responses. In this study, we have examined the regulation of OX40 gene expression in T cells. Low-level OX40 mRNA expression was detected in both resting T cells and the nonactivated EL4 T cell line, and was up-regulated in both types of T cells upon activation with anti-CD3 Ab. We have shown in this study that basal OX40 promoter activity is regulated by constitutively expressed Sp1/Sp3 and YY1 transcription factors. NF-kappa B (p50 and p65) also binds to the OX40 promoter region, but the level of direct enhancement of the OX40 promoter activity by this transcription factor is not sufficient to account for the observed up-regulation of OX40 mRNA expression associated with activation. We have detected by chromatin immunoprecipitation that histone H4 molecules in the OX40 promoter region are highly acetylated by activation and NF-kappa B binds to the OX40 promoter in vivo. These findings suggest that OX40 gene expression is regulated by chromatin remodeling, and that NF-kappa B might be involved in initiation of chromatin remodeling in the OX40 promoter region in activated T cells. CD4(+)CD25(+) regulatory T (Treg) cells also express OX40 at high levels, and signaling through this receptor can neutralize suppressive activity of this Treg cell. In CD4(+)CD25(+) Treg cells, histone H4 molecules in the OX40 promoter region are also highly acetylated, even in the absence of in vitro activation.
引用
收藏
页码:1760 / 1767
页数:8
相关论文
共 45 条
  • [1] Identification of three NFAT binding motifs in the 5′-upstream region of the human CD3γ gene that differentially bind NFATc1, NFATc2, and NF-κB p50
    Badran, BM
    Wolinsky, SM
    Burny, A
    Willard-Gallo, KE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) : 47136 - 47148
  • [2] AU-rich elements and associated factors: are there unifying principles?
    Barreau, C
    Paillard, L
    Osborne, HB
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (22) : 7138 - 7150
  • [3] Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO
  • [4] 2-8
  • [5] Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions
    Chen, AI
    McAdam, AJ
    Buhlmann, JE
    Scott, S
    Lupher, ML
    Greenfield, EA
    Baum, PR
    Fanslow, WC
    Calderhead, DM
    Freeman, GJ
    Sharpe, AH
    [J]. IMMUNITY, 1999, 11 (06) : 689 - 698
  • [6] AU-RICH ELEMENTS - CHARACTERIZATION AND IMPORTANCE IN MESSENGER-RNA DEGRADATION
    CHEN, CYA
    SHYU, AB
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (11) : 465 - 470
  • [7] A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-κB and NFAT families
    de Lumley, M
    Hart, DJ
    Cooper, MA
    Symeonides, S
    Blackburn, JM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 339 (05) : 1059 - 1075
  • [8] RAPID PRODUCTION OF FULL-LENGTH CDNAS FROM RARE TRANSCRIPTS - AMPLIFICATION USING A SINGLE GENE-SPECIFIC OLIGONUCLEOTIDE PRIMER
    FROHMAN, MA
    DUSH, MK
    MARTIN, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 8998 - 9002
  • [9] Structure of NFAT1 bound as a dimer to the HIV-1 LTR κB element
    Giffin, MJ
    Stroud, JC
    Bates, DL
    von Koenig, KD
    Hardin, J
    Chen, L
    [J]. NATURE STRUCTURAL BIOLOGY, 2003, 10 (10) : 800 - 806
  • [10] Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
    Gordon, S
    Akopyan, G
    Garban, H
    Bonavida, B
    [J]. ONCOGENE, 2006, 25 (08) : 1125 - 1142